Relationship between hand grip strength and peak VO2 in community-dwelling elderly outpatients

Masamitsu Sugie, Kazumasa Harada, Tetsuya Takahashi, Marina Nara, Joji Ishikawa, Jun Tanaka, Teruyuki Koyama, Hajime Fujimoto, Shuichi Obuchi, Shunei Kyo, Hideki Ito


Background: Hand grip strength and peak oxygen uptake (VO2) are important components of frailty. However, the relationship between these two variables among community-dwelling elderly people is still unclear. The present study aimed to investigate this relationship.

Methods: Participants were 190 Japanese community-dwelling elderly outpatients (61 men and 129 women, mean age 78.0 years). Hand grip strength of participants’ dominant hand was measured using a Smedley-type hand dynamometer. Peak VO2 levels were assessed with a cardiopulmonary exercise test. Skeletal muscle mass index (SMI) and usual walking speed were assessed physiologically and physically. Sample size was calculated using G*Power

Results: There were significant correlations between hand grip strength and age (r = −0.22), peak VO2 (r = 0.40), SMI (r = 0.51), and usual walking speed (r = 0.29). There were significant differences in age, peak VO2 and SMI after participants were divided into normal and low hand grip strength groups according to the Asian Working Group for Sarcopenia threshold, whether both sexes were combined or considered separately. Multiple logistic regression analysis showed that peak VO2, SMI and age were independent determinants of hand grip strength after adjusting for potential confounders (Exp(B) = 0.871; 0.475; 1.065). Longitudinal analysis after 6 months of exercise training showed the percentage of change in hand grip strength and peak VO2 were correlated positively (r = 0.22) for 92 participants.

Conclusion: Peak VO2 is independently associated with hand grip strength among community-dwelling elderly outpatients.



Full Text:




(1) Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):M146–56.

(2) Giampaoli S, Ferrucci L, Cecchi F, Lo Noce C, Poce A, Dima F, Santaquilani A, Vescio MF, Menotti A. Hand-grip strength predicts incident disability in non-disabled older men. Age Ageing 1999; 28:283–8.

(3) Metter EJ, Talbot LA, Schrager M, Conwit R. Skeletal muscle strength as a predictor of all-cause mortality in healthy men. J Gerontol A Biol Sci Med Sci 2002; 57:B359-65.

(4) Silventoinen K, Magnusson PK, Tynelius P Batty GD, Rasmussen F. Association of body size and muscle strength with incidence of coronary heart disease and cerebrovascular diseases: A population-based cohort study of one million Swedish men. Int J Epidemiol 2009; 38:110–8.

(5) Rantanen T, Volpato S, Ferrucci L Heikkinen E, Fried LP, Guralnik JM. Handgrip strength and cause-specific and total mortality in older disabled women: Exploring the mechanism. J Am Geriatr Soc 2003; 51:636–641.

(6) Wasserman K, Van Kessel AL, Burton GG. Interaction of physiological mechanisms during exercise. J Appl Physiol 1967; 22(1):71–85.

(7) Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002; 346(11):793–801.

(8) Hughes AD, Chaturvedi N. Estimation of maximal oxygen consumption and heart rate recovery using the Tecumseh Sub-Maximal Step Test and their relationship to cardiovascular risk factors. Artery Res 2017; 18:29–35.

(9) Fletcher GF, Ades PA, Kligfield P Arena R, Balady GJ, Bittner VA, Coke LA, Fleg JL, Forman DE, Gerber TC, Gulati M, Madan K, Rhodes J, Thompson PD, Williams MA; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation 2013; 128:873–934.

(10) Lang CC, Karlin P, Haythe J, Tsao L, Mancini DM. Ease of noninvasive measurement of cardiac output coupled with peak VO2 determination at rest and during exercise in patients with heart failure. Am J Cardiol 2007; 99(3):404–5.

(11) Ehsani AA, Spina RJ, Peterson LR, Rinder MR, Glover KL, Villareal DT, Binder EF, Holloszy JO. Attenuation of cardiovascular adaptations to exercise in frail octogenarians. J Appl Physiol 2003; 95:1781–8.

(12) Chen LK, Lee WJ, Peng LN, Liu LK, Arai H, Akishita M; Asian Working Group for Sarcopenia. Recent advances in sarcopenia research in Asia: 2016 update from the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2016; 17(8):767.e1–7.

(13) Balady GJ, Ades PA, Comoss P, Limacher M, Pina IL, Southard D, Williams MA, Bazzarre T. Core components of cardiac rehabilitation/secondary prevention programs: a statement for healthcare professionals from the American Heart Association and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation 2000; 102(9):1069–73.

(14) Kim H, Hirano H, Edahiro A, Ohara Y, Watanabe Y, Kojima N, Kim M, Hosoi E, Yoshida Y, Yoshida H, Shinkai S. Sarcopenia: Prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int 2016; 16 Suppl 1:110–22.

(15) Sugie M, Harada K, Takahashi T, Nara M, Ishikawa J, Koyama T, Kim H, Tanaka J, Fujimoto H, Obuchi PS, von Haehling S, Kyo S, Ito H. Relationship between skeletal muscle mass and cardiac function during exercise in community-dwelling older adults. ESC Heart Failure Version of Record online: 10 APR 2017, DOI: 10.1002/ehf2.12158.

(16) Gubelmann C, Vollenweider P, Marques-Vidal P. No association between grip strength and cardiovascular risk: The CoLaus population-based study. Int J Cardiol 2017; 236:478–82.

(17) Sandbakk SB, Nauman J, Zisko N, Sandbakk Ø, Aspvik NP, Stensvold D, Wisløff U. Sedentary time, cardiorespiratory fitness, and cardiovascular risk factor clustering in older adults--the Generation 100 study. Mayo Clin Proc 2016; 91(11):1525–34.

(18) Oliveira RG, Guedes DP. Physical activity, sedentary behavior, cardiorespiratory fitness and metabolic syndrome in adolescents: systematic review and meta-analysis of observational evidence. PLoS One 2016 Dec 20; 11(12):e0168503. doi: 10.1371/journal.pone.0168503. eCollection 2016.

(19) Peterson MD, Duchowny K, Meng Q, Wang Y, Chen X, Zhao Y. Low normalized grip strength is a biomarker for cardiometabolic disease and physical disabilities among U.S. and Chinese adults. J Gerontol A Biol Sci Med Sci 2017. [Epub ahead of print]

(20) Pérez-Tasigchana RF, León-Muñoz LM, Lopez-Garcia E, Gutierrez-Fisac JL, Laclaustra M, Rodríguez-Artalejo F, Guallar-Castillón P. Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study. Age Ageing 2017 Mar 1:1-6. doi: 10.1093/ageing/afx023.

(21) Han DS, Chen YM, Lin SY, Chang HH, Huang TM, Chi YC, Yang WS. Serum myostatin levels and grip strength in normal subjects and patients on maintenance haemodialysis. Clin Endocrinol (Oxf). 2011; 75(6):857–63.

(22) Patel HP, Al-Shanti N, Davies LC, Barton SJ, Grounds MD, Tellam RL, Stewart CE, Cooper C, Sayer AA. Lean mass, muscle strength and gene expression in community dwelling older men: findings from the Hertfordshire Sarcopenia Study (HSS). Calcif Tissue Int. 2014; 95(4):308–16.

(23) Whittemore LA, Song K, Li X, Aghajanian J, Davies M, Girgenrath S, Hill JJ, Jalenak M, Kelley P, Knight A, Maylor R, O'Hara D, Pearson A, Quazi A, Ryerson S, Tan XY, Tomkinson KN, Veldman GM, Widom A, Wright JF, Wudyka S, Zhao L, Wolfman NM. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength. Biochem Biophys Res Commun 2003; 300(4):965–71.

(24) Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP, Hochberg MC, Ferrari SL, Blain H, Binder EF,Rolland Y, Poiraudeau S, Benson CT, Myers SL, Hu L, Ahmad QI, Pacuch KR, Gomez EV, Benichou O; STEADY Group. Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 2015; 3(12):948–57.

(25) Brandt C, Nielsen AR, Fischer CP, Hansen J, Pedersen BK, Plomgaard P. Plasma and muscle myostatin in relation to type 2 diabetes. PLoS One 2012; 7(5):e37236.

(26) Kung T, Szabó T, Springer J, Doehner W, Anker SD, von Haehling S. Cachexia in heart disease: highlights from the ESC 2010. J Cachexia Sarcopenia Muscle 2011; 2(1):63–9.

(27) Cunha TF, Bacurau AV, Moreira JB, Paixão NA, Campos JC, Ferreira JC, Leal ML, Negrão CE, Moriscot AS, Wisløff U, Brum PC. Exercise training prevents oxidative stress and ubiquitin-proteasome system overactivity and reverse skeletal muscle atrophy in heart failure. PLoS One 2012; 7(8):e41701.

(28) Takahashi T, Sugie M, Nara M, Koyama T, Obuchi SP, Harada K, Kyo S, Ito H. Femoral muscle mass relates to physical frailty components in community-dwelling older people. Geriatr Gerontol Int 2017 [Epub ahead of print].

(29) von Haehling S, Ebner N, Morley JE, Coats AJ, Anker SD. Ethical guidelines for authorship and publishing in the Journal of Cachexia, Sarcopenia and Muscle Clinical Report. J Cachexia Sarcopenia Muscle Clinical Reports 2016;1;e1:1‐2.



  • There are currently no refbacks.